Genome-wide DNA methylation patterns in CD4+ T cells from patients with systemic lupus erythematosus

Systemic lupus erythematosus is a chronic-relapsing autoimmune disease of incompletely understood etiology. Recent evidence strongly supports an epigenetic contribution to the pathogenesis of lupus. To understand the extent and nature of dysregulated DNA methylation in lupus T cells, we performed a genome-wide DNA methylation study in CD4+ T cells in lupus patients compared to normal healthy controls. Cytosine methylation was quantified in 27,578 CG sites located within the promoter regions of 14,495 genes. We identified 236 hypomethylated and 105 hypermethylated CG sites in lupus CD4+ T cells compared to normal controls, consistent with widespread DNA methylation changes in lupus T cells. Of interest, hypomethylated genes in lupus T cells include CD9, which is known to provide potent T-cell co-stimulation signals. Other genes with known involvement in autoimmunity such as MMP9 and PDGFRA were also hypomethylated. The BST2 gene, an interferon-inducible membrane-bound protein that helps restrict the release of retroviral particles was also hypomethylated in lupus patients. Genes involved in folate biosynthesis, which plays a role in DNA methylation, were overrepresented among hypermethylated genes. In addition, the transcription factor RUNX3 was hypermethylated in patients, suggesting an impact on T-cell maturation. Protein-protein interaction maps identified a transcription factor, HNF4a, as a regulatory hub affecting a number of differentially methylated genes. Apoptosis was also an overrepresented ontology in these interaction maps. Further, our data suggest that the methylation status of RAB22A, STX1B2, LGALS3BP, DNASE1L1 and PREX1 correlates with disease activity in lupus patients.

[1]  J. Harley,et al.  Autoimmunity and Klinefelter's syndrome: when men have two X chromosomes. , 2009, Journal of autoimmunity.

[2]  B. Richardson,et al.  Mechanisms of drug-induced lupus. IV. Comparison of procainamide and hydralazine with analogs in vitro and in vivo. , 1997, Arthritis and rheumatism.

[3]  A. Puig-Kröger,et al.  RUNX3 regulates the activity of the CD11a and CD49d integrin gene promoters. , 2005, Immunobiology.

[4]  M. Jeffries,et al.  Defective DNA methylation and CD70 overexpression in CD4+ T cells in MRL/lpr lupus‐prone mice , 2007, European journal of immunology.

[5]  Y. Okada,et al.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis , 2000, Annals of the rheumatic diseases.

[6]  Tao Han,et al.  A microarray study of MPP+-treated PC12 Cells: Mechanisms of toxicity (MOT) analysis using bioinformatics tools , 2005, BMC Bioinformatics.

[7]  A. Rosen,et al.  Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes , 1994, The Journal of experimental medicine.

[8]  Dongxiao Zhu,et al.  BMC Bioinformatics BioMed Central , 2005 .

[9]  N. Knowlton,et al.  Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients , 2008, Genes and Immunity.

[10]  T. Magnuson,et al.  Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis. , 2010, The Journal of clinical investigation.

[11]  J. Herman,et al.  Alterations in DNA methylation: a fundamental aspect of neoplasia. , 1998, Advances in cancer research.

[12]  G. Remuzzi,et al.  Imatinib ameliorates renal disease and survival in murine lupus autoimmune disease. , 2006, Kidney international.

[13]  Fatima Al-Shahrour,et al.  Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. , 2010, Genome research.

[14]  M. Wainberg,et al.  Tetherin restricts direct cell-to-cell infection of HIV-1 , 2010, Retrovirology.

[15]  J. Mason,et al.  DNA hypomethylation in inflammatory arthritis: reversal with methotrexate. , 1996, The Journal of laboratory and clinical medicine.

[16]  I. Dozmorov,et al.  Internal standard-based analysis of microarray data. Part 1: analysis of differential gene expressions , 2009, Nucleic acids research.

[17]  Nicholas Knowlton,et al.  Hypervariable genes--experimental error or hidden dynamics. , 2004, Nucleic acids research.

[18]  Q. Lu,et al.  Demethylation of CD40LG on the Inactive X in T Cells from Women with Lupus1 , 2007, The Journal of Immunology.

[19]  Jonathan D. Wren,et al.  Shared relationship analysis: ranking set cohesion and commonalities within a literature-derived relationship network , 2004, Bioinform..

[20]  N. Copeland,et al.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.

[21]  Jonathan D Wren,et al.  Differential activation profiles of multiple transcription factors during dendritic cell maturation. , 2005, The Journal of investigative dermatology.

[22]  S Hanash,et al.  Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. , 1990, Arthritis and rheumatism.

[23]  S. Hanash,et al.  Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors. , 2004, Arthritis and rheumatism.

[24]  Zhiyong Zhang,et al.  Age-dependent DNA methylation changes in the ITGAL (CD11a) promoter , 2002, Mechanisms of Ageing and Development.

[25]  M. Petri,et al.  Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. , 2008, Arthritis and rheumatism.

[26]  D. Gutsch,et al.  Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. , 2002, Arthritis and rheumatism.

[27]  Tiffany Telarico,et al.  Endogenous retroviral pathogenesis in lupus , 2010, Current opinion in rheumatology.

[28]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[29]  Jonathan D. Wren,et al.  A global meta-analysis of microarray expression data to predict unknown gene functions and estimate the literature-data divide , 2009, Bioinform..

[30]  Steffen Jung,et al.  Runx3 regulates mouse TGF‐β‐mediated dendritic cell function and its absence results in airway inflammation , 2004, The EMBO journal.

[31]  C. Van Lint,et al.  CpG methylation controls reactivation of HIV from latency , 2010, Retrovirology.

[32]  Peisong Chen,et al.  Epigenetic programming of diverse glucocorticoid response and inflammatory/immune-mediated disease. , 2009, Medical hypotheses.

[33]  Ronald H. Schwartz,et al.  Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process , 2003, Nature Immunology.

[34]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[35]  J. Harley,et al.  Aberrant Epstein-Barr viral infection in systemic lupus erythematosus. , 2009, Autoimmunity reviews.

[36]  J. Kalden.  Defective Phagocytosis of Apoptotic Cells: Possible Explanation for the Induction of Autoantibodies in SLE , 1997, Lupus.

[37]  Thorsten Dickhaus,et al.  Epigenetic quantification of tumor-infiltrating T-lymphocytes , 2011, Epigenetics.

[38]  T. Hughes,et al.  DNA methylome in human CD4+ T cells identifies transcriptionally repressive and non-repressive methylation peaks , 2010, Genes and Immunity.

[39]  S. Takeshita,et al.  Functional Association of CD9 with the Fcγ Receptors in Macrophages1 , 2001, The Journal of Immunology.

[40]  O. Rekvig,et al.  Deposition of chromatin‐IgG complexes in skin of nephritic MRL‐lpr/lpr mice is associated with increased local matrix metalloprotease activities , 2009, Experimental dermatology.

[41]  W. Emlen,et al.  Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. , 1994, Journal of immunology.

[42]  S. Hanash,et al.  Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. , 2001, Arthritis and rheumatism.

[43]  M. Kapembwa,et al.  HIV and systemic lupus erythematosus: the clinical and diagnostic dilemmas of having dual diagnosis , 2010, International journal of STD & AIDS.

[44]  Autoantibodies against platelet-derived growth factor receptor alpha in patients with systemic lupus erythematosus , 2010, Modern rheumatology.

[45]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[46]  R. Pinto,et al.  Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjögren's syndrome. , 2000, Arthritis and rheumatism.

[47]  T. Horiuchi,et al.  Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. , 1999, Arthritis and rheumatism.

[48]  Y. Liu,et al.  Age-dependent decreases in DNA methyltransferase levels and low transmethylation micronutrient levels synergize to promote overexpression of genes implicated in autoimmunity and acute coronary syndromes , 2010, Experimental Gerontology.

[49]  D. Kamen,et al.  Haemolytic anaemia in a multi-ethnic cohort of lupus patients: a clinical and serological perspective , 2008, Lupus.

[50]  S. Takeshita,et al.  Functional association of CD9 with the Fc gamma receptors in macrophages. , 2001, Journal of immunology.

[51]  A. Delgado-Vega,et al.  Recent findings on genetics of systemic autoimmune diseases. , 2010, Current opinion in immunology.

[52]  H. Fujiwara,et al.  A role for CD9 molecules in T cell activation , 1996, The Journal of experimental medicine.

[53]  J. Harley,et al.  An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. , 1997, The Journal of clinical investigation.

[54]  J. O’Sullivan,et al.  Generation of an epigenetic signature by chronic hypoxia in prostate cells. , 2009, Human molecular genetics.

[55]  D. Vaux,et al.  Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Q. Lu,et al.  T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus. , 2009, Clinical immunology.